Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a *non-coding, antisense transcript* expressed opposite the C10orf76 gene on chromosome 10. Antisense transcripts are often involved in regulation of their sense counterparts, affecting mRNA stability, splicing, or translation, but there is **no direct evidence or functional annotation for this specific transcript**. The recognized protein product at this locus is C10orf76 (ARMH3), which is a protein implicated in Golgi phosphoinositide signaling and positive regulation of certain enterovirus replication[1][3][5]. The antisense transcript itself is not currently recognized as a molecular target or therapeutic entity. Important caveats: This transcript is not a classical drug target and lacks functional, structural, or disease data. "ENSG00000308403" may be a misspelled or semi-annotated gene ID; if you meant the protein-coding gene C10orf76, then the entry should reference "C10orf76" (aka ARMH3). No standardized abbreviation or official symbol exists for unspecified antisense transcripts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript antisense to C10orf76 (ENSG00000308403).